Corvus Pharmaceuticals Ownership | Who Owns Corvus Pharmaceuticals?
Corvus Pharmaceuticals Ownership Summary
Corvus Pharmaceuticals is owned by 32.32% institutional investors, 3.52% insiders, and 64.16% retail investors. Orbimed advisors is the largest institutional shareholder, holding 9.21% of CRVS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.79% of its assets in Corvus Pharmaceuticals shares.
CRVS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Corvus Pharmaceuticals | 32.32% | 3.52% | 64.16% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Orbimed advisors | 7.17M | 9.21% | $52.81M |
| Point72 asset management | 6.45M | 8.30% | $47.57M |
| Blackrock funding, inc. /de | 5.06M | 6.10% | $38.93M |
| Vanguard group | 3.87M | 4.68% | $29.83M |
| Morgan stanley | 3.57M | 4.31% | $27.47M |
| Adams street partners | 3.28M | 4.21% | $24.14M |
| Rtw investments, lp | 2.68M | 3.45% | $19.75M |
| Vivo capital | 2.23M | 2.87% | $16.47M |
| Foresite capital management vi | 1.73M | 2.23% | $12.76M |
| Perceptive advisors | 1.44M | 1.85% | $10.60M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Adams street partners | 3.28M | 15.76% | $24.14M |
| Foresite capital management vi | 1.73M | 4.93% | $12.76M |
| Dcf advisers | 729.00K | 1.51% | $5.61M |
| Vivo capital | 2.23M | 1.33% | $16.47M |
| Orbimed advisors | 7.17M | 1.24% | $52.81M |
| Towerview | 140.00K | 0.78% | $1.08M |
| Sphera funds management | 407.71K | 0.63% | $3.00M |
| Perceptive advisors | 1.44M | 0.31% | $10.60M |
| Rtw investments, lp | 2.68M | 0.24% | $19.75M |
| Stempoint capital lp | 96.44K | 0.14% | $710.75K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Morgan stanley | 3.57M | 0.00% | 2.95M |
| Susquehanna group, llp | 1.02M | 0.00% | 796.12K |
| Dcf advisers | 729.00K | 1.51% | 729.00K |
| Vanguard group | 3.87M | 0.00% | 401.56K |
| Blackrock funding, inc. /de | 5.06M | 0.00% | 345.92K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Samlyn capital | - | - | -4.07M |
| Deerfield management company, l.p. (series c) | - | - | -1.00M |
| Point72 asset management | 6.45M | 0.08% | -588.10K |
| Gsa capital partners llp | 14.19K | 0.01% | -387.22K |
| Bvf inc/il | - | - | -361.41K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Stempoint capital lp | 96.44K | 0.14% | 96.44K | $710.75K |
| Alps advisors | 61.32K | 0.00% | 61.32K | $472.15K |
| Neos investment management | 59.20K | 0.00% | 59.20K | $436.32K |
| Profund advisors | 37.06K | 0.01% | 37.06K | $285.38K |
| Quest partners | 35.97K | 0.02% | 35.97K | $276.98K |
Sold Out
| Holder | Change |
|---|---|
| Parallel advisors | -20.00 |
| Ifp advisors | -24.00 |
| Eversource wealth advisors | -60.00 |
| Ica group wealth management | -165.00 |
| Comerica bank | -365.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 83 | -22.43% | 26,771,704 | -35.76% | 32 | 1.13% | 44 | -25.42% | 17 | - |
| Sep 30, 2025 | 106 | 6.00% | 41,641,007 | -0.34% | 53 | 1.86% | 59 | -7.81% | 17 | 21.43% |
| Jun 30, 2025 | 99 | -4.81% | 41,766,678 | 15.16% | 53 | 2.12% | 63 | 61.54% | 13 | -55.17% |
| Mar 31, 2025 | 104 | 2.97% | 36,268,523 | -3.73% | 50 | 1.58% | 40 | -41.18% | 29 | 190.00% |
| Dec 31, 2024 | 100 | 38.89% | 37,670,552 | 25.42% | 56 | 2.79% | 67 | 71.79% | 10 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.34M | 2.79% | 349.80K |
| Vanguard US Total Market Shares ETF | 1.58M | 2.32% | - |
| State Street® SPDR® S&P® Biotech ETF | 1.71M | 2.04% | -9.20K |
| iShares Russell 2000 ETF | 1.38M | 1.65% | 1.38M |
| Vanguard Institutional Extnd Mkt Idx Tr | 785.05K | 0.94% | 78.14K |
| Fidelity Small Cap Index | 602.33K | 0.72% | 8.86K |
| MEDICAL BioHealth EUR Acc | 499.11K | 0.60% | 499.11K |
| iShares Russell 2000 Growth ETF | 476.87K | 0.57% | 476.87K |
| iShares Biotechnology ETF | 423.58K | 0.51% | 423.58K |
| Fidelity Extended Market Index | 345.76K | 0.41% | 3.34K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 27, 2025 | ORBIMED ADVISORS LLC | Sell | $4.89M | |
| Jun 27, 2025 | Thompson Peter A. | Sell | $4.89M | |
| May 06, 2024 | Thompson Peter A. | Buy | $144.41 | |
| May 06, 2024 | Thompson Peter A. | Buy | $4.89M | |
| May 06, 2024 | ORBIMED ADVISORS LLC | Buy | $144.41 |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q2 | - | 2 |
| 2024 Q4 | - | - |
| 2024 Q2 | 8 | - |
CRVS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools